| Literature DB >> 34199588 |
Benjamin Wax1, Chad M Kerksick2, Andrew R Jagim3, Jerry J Mayo4, Brian C Lyons5, Richard B Kreider6.
Abstract
Creatine is one of the most studied and popular ergogenic aids for athletes and recreational weightlifters seeking to improve sport and exercise performance, augment exercise training adaptations, and mitigate recovery time. Studies consistently reveal that creatine supplementation exerts positive ergogenic effects on single and multiple bouts of short-duration, high-intensity exercise activities, in addition to potentiating exercise training adaptations. In this respect, supplementation consistently demonstrates the ability to enlarge the pool of intracellular creatine, leading to an amplification of the cell's ability to resynthesize adenosine triphosphate. This intracellular expansion is associated with several performance outcomes, including increases in maximal strength (low-speed strength), maximal work output, power production (high-speed strength), sprint performance, and fat-free mass. Additionally, creatine supplementation may speed up recovery time between bouts of intense exercise by mitigating muscle damage and promoting the faster recovery of lost force-production potential. Conversely, contradictory findings exist in the literature regarding the potential ergogenic benefits of creatine during intermittent and continuous endurance-type exercise, as well as in those athletic tasks where an increase in body mass may hinder enhanced performance. The purpose of this review was to summarize the existing literature surrounding the efficacy of creatine supplementation on exercise and sports performance, along with recovery factors in healthy populations.Entities:
Keywords: athletic performance; ergogenic aid; muscle damage; muscular adaptation; muscular power; recovery; resistance exercise; supplementation; training; weightlifting
Year: 2021 PMID: 34199588 PMCID: PMC8228369 DOI: 10.3390/nu13061915
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Potential ergogenic benefits of creatine supplementation.
| • Increased single and repetitive sprint performance |
| • Increased work performed during sets of maximal effort muscle contractions |
| • Increased muscle mass and strength adaptations during training |
| • Enhanced glycogen synthesis |
| • Increased anaerobic threshold |
| • Possible enhancement of aerobic capacity via greater shuttling of ATP from mitochondria |
| • Increased work capacity |
| • Enhanced recovery |
| • Greater training tolerance |
Adopted from Kreider et al. 2017 [3].
Examples of sports and activities in which performance may be enhanced by creatine supplementation.
|
|
| • Track sprints: 60–200 m |
| • Swim sprints: 50 m |
| • Pursuit cycling |
|
|
| • Basketball |
| • Field hockey |
| • America Football |
| • Ice hockey |
| • Lacrosse |
| • Volleyball |
|
|
| • Downhill skiing |
| • Water Sports (e.g., Rowing, Canoeing, Kayaking, Stand-Up Paddling) |
| • Swim events: 100, 200 m |
| • Track events: 400, 800 m |
| • Combat Sports (e.g., MMA, Wrestling, Boxing, etc.) |
|
|
| • Basketball |
| • Soccer |
| • Team handball |
| • Tennis |
| • Volleyball |
| • Interval Training in Endurance Athletes |
|
|
| • American Football |
| • Bodybuilding |
| • Combat Sports (e.g., MMA, Wrestling, Boxing, etc.) |
| • Powerlifting |
| • Rugby |
| • Track/Field events (Shot put; Javelin; Discus; Hammer Throw) |
| • Olympic Weightlifting |
Adopted from Kreider et al. 2017 [3].
Figure 1General flow diagram highlighting the selection process for included articles.
Summary of selected studies examining the acute effects of creatine monohydrate on strength performance.
| Author and Year | Subjects | Duration | Dosing | Primary Variables | Results | Adverse Events |
|---|---|---|---|---|---|---|
| Peak Torque/Force Production | ||||||
| Greenhaff et al. 1993 | 12 healthy males | 5 days | 20/d for 5 days | isokinetic performance during repeated intervals | ↑ muscle torque | None reported |
| Casey et al. 1996 | 9 active males | 5 days | 20 g/day for 5 days | cycling sprint performance | ↑ total work | None reported |
| Gilliam et al. 2000 | 23 healthy males | 5 days | 20 g/day for 5 days | isokinetic performance of quadriceps | ↔ muscle torque | None reported |
| Rossouw et al. 2000 | 13 trained powerlifters | 5 days | 9 g/day for 5 days | isokinetic knee extension | ↑ peak torque | None reported |
| Kilduff et al. 2002 | 32 trained males | 5 days | 20 g/day for 5 days | isometric bench press | ↑ peak force | None reported |
| Strength Performance | ||||||
| Birch et al. 1994 | 14 healthy males | 5 days | 20 g/day for 5 days | isokinetic cycling performance during repeated intervals | ↑ mean power output | None reported |
| Barnett et al.1996 | 17 active males | 4 days | 280 mg/kg for 4 days | 10 s sprints on a cycle ergometer | ↔ mean power output | None reported |
| Strength and Performance Outcomes | ||||||
| Edwards et al. 2000 | 21 active males | 6 days | 20 g/d for 6 days | anaerobic intervals on a treadmill | ↔ speed test performance | None reported |
| Rockwell et al. 2001 | 16 trained males | 4 days | 20 g/day for 4 days | repeated cycling sprints | ↔ total work | None reported |
| Volek et al. 2001 | 10 healthy males | 7 days | 0.3 g/kg for 7 days | repeated cycling sprints | ↔ cardiovascular or thermoregulatory responses | None reported |
| Finn et al. 2001 | 16 male triathletes | 5 days | 20 g/day for 5 days | repeated cycling sprints | ↔ peak power | None reported |
| Ziegenfuss et al. 2002 | 20 (10 male, 10 female) power athletes | 3 days | 0.35 g/kg of fat-free mass for 3 days | repeated cycling sprints | ↑ peak power | None reported |
| Yquel et al. 2002 | 9 healthy males | 6 days | 20 g/day for 6 days | repeated dynamic plantar flexion | ↑ mean power | None reported |
| Delecluse et al. 2003 | 12 (7 male, 5 female) competitive sprinters | 7 days | 0.35 g/day for 7 days | single 40-m sprint | ↔ single 40-m sprint | None reported |
| Kocak et al. 2003 | 20 elite male wrestlers | 5 days | 20 g/day for 5 days | average and peak power during wingate anaerobic power test | ↑ average power | None reported |
| Selsby et al. 2004 | 31 trained males | 10 days | 2.5 g/day for 10 days | bench press strength | ↔ bench press strength | None reported |
| Zuniga et al. 2012 | 22 active males | 7 days | 20 g/day for 7 days | wingate cycling test | ↑ mean power output | None reported |
| del Favero et al. 2012 | 34 untrained males | 10 days | 20 g/day for 10 days | lower body strength | ↑ bench press | None reported |
| Wang et al. 2017 | 17 high school canoeists | 6 days | 20 g/day for 6 days | upper body strength | ↑ upper body strength | None reported |
BLa = blood lactate; CR or no identifier = creatine monohydrate; ↓ indicates decrease; ↑ indicates increase; ↔ indicates no difference.
Summary of selected studies examining the long-term (>2 weeks) effects on strength performance.
| Author and Year | Subjects | Duration | Dosing Protocol | Primary Variables | Results | Adverse Events |
|---|---|---|---|---|---|---|
| Peak Torque/Force Production | ||||||
| Stevenson et al. 2001 | 18 (17 males, 1 female) trained subjects | 9 weeks | 20 g/day for 7 days | maximal torque on isokinetic dynamometer | ↔ maximal torque | None reported |
| Chrusch et al. 2001 | 30 healthy older males | 12 weeks | 0.03 g/kg/day for 5 days | lean tissue | ↑ lean tissue | None reported |
| Strength | ||||||
| Vandenberghe et al.1997 | 19 healthy female subjects | 11 weeks | 5 g/day for 4 days | arm flexion on isokinetic dynamometer | ↑ arm torque | None reported |
| Kelly et al. 1998 | 18 male powerlifters | 26 days | 20 g/day for 5 days | bench press strength | ↑ bench press strength | None reported |
| Volek et al. 1999 | 19 trained males | 12 weeks | 25 g/day for 7 days | body mass | ↔ body mass | None reported |
| Becque et al. 2000 | 23 trained males | 6 weeks | 20 g/day for 5 days | upper body strength | ↑ arm flexor strength | None reported |
| Brenner et al. 2000 | 20 female college lacrosse players | 5 weeks | 20 g/day for 7 days | body composition | ↔ body composition | None reported |
| Larson-Meyer et al. 2000 | 14 female college soccer players | 13 weeks | 15 g/day for 5 days | bench press strength | ↑ bench press strength | 1 subject reported nausea |
| Bemben et al. 2001 | 25 male college football players | 9 weeks | 20 g/day for 5 days | bench press strength | ↑ bench press strength | None reported |
| Burke et al. 2001 | 47 active male subjects | 21 days | 7.7 g/day for 21 days | bench press on a isokinetic dynamometer | ↑ peak force | None reported |
| Chrusch et al. 2001 | 30 healthy older males | 12 weeks | 0.03 g/kg/day for 5 days | lean tissue | ↑ lean tissue | None reported |
| Wilder et al. 2001 | 25 male college football players | 10 weeks | 3 g/day for 10 week or | squat strength | ↔ squat strength | None reported |
| Burke et al. 2003 | 49 (20 male, 29 female) active subjects | 8 weeks | 0.25 g/kg lean tissue/day for 7 days | bench press strength | ↑ bench press | None reported |
| Ferguson et al. 2006 | 26 trained females | 10 weeks | 0.3 g/kg for 7 days | bench press strength | ↔ bench press | None reported |
| Kerksick et al. 2009 | 24 trained males | 4 weeks | 20 g/day for 5 days | bench press strength | ↑ bench press | None reported |
| Camic et al. 2010 | 22 untrained males | 28 days | 5 g/day for 28 days | bench press strength | ↑ bench press | None reported |
| Hummer et al. 2019 | 22 (16 males, 6 females) active subjects | 6 weeks | 4 g/day for 6 weeks | bench press strength | ↑ bench press strength | None reported |
| Strength and Performance Outcomes | ||||||
| Kreider et al. 1998 | 25 college football players | 28 days | 15.75 g/day for 28 days | total work during sprints on a cycle ergometer | ↑ total work | None reported |
| Stone et al. 1999 | 42 college football players | 5 weeks | 0.22 g/kg/day for 5 weeks | bench press strength | ↑ bench press strength | None reported |
| Chilibeck, et al. 2007 | 19 male union rugby players | 8 weeks | 0.7 g/kg/day for 8 weeks | bench press endurance | ↔ bench press repetitions | None reported |
BLa = blood lactate; CR or no identifier = creatine monohydrate; ↓ indicates decrease; ↑ indicates increase; ↔ indicates no difference.
Summary of selected studies examining the effects of creatine supplementation on sport performance.
| Author Year | Subjects | Duration | Dosing Protocol | Primary Variables | Results | Adverse Events |
|---|---|---|---|---|---|---|
| Grindstaff et al. 1997 | 18 (7 male, 11 female) junior competitive swimmers | 9 days | 21 g/day for 9 days | 100-m sprint | ↑ sprint swimming performance | None reported |
| Kreider et al. 1998 | 25 college football players | 28 days | 15.75 g/day for 28 days | total work during sprints on a cycle ergometer | ↑ total work | None reported |
| Noonan et al. 1998 | 39 college football players | 9 weeks | 20 g/day for 5 days | bench press | ↑ bench press | None reported |
| Peyrebrune et al. 1998 | 14 male college swimmers | 5 days | 9 g/day for 5 days | single 50-m sprint time | ↔ single 50 m sprint time | None reported |
| Stout et al. 1999 | 24 college football players | 8 weeks | 21 g/day for 5 days | vertical jump | ↑ vertical jump | None reported |
| Jones et al. 1999 | 8 elite ice hockey players | 11 weeks | 20 g/day for 5 days | 5 × 15 s skating sprints | ↑ 5 × 15 s skating sprints | None reported |
| Kirksey et al. 1999 | 36 (16 male, 20 female) track and field athletes | 6 weeks | 0.3 g/kg/day | countermovement vertical jump | ↑ countermovement vertical jump | None reported |
| Kreider et al. 1999 | 61 college football players | 12 weeks | 20–25 g/day | Bench press strength | ↑ bench press strength | None reported |
| Mujika et al. 2000 | 17 trained soccer players | 10 weeks | 20 g/day for 5 days | countermovement jump | ↔ countermovement jump | None reported |
| Haff et al. 2000 | 36 (16 male, 20 female) track and field athletes | 6 weeks | 0.3 g/kg/day | countermovement vertical jump | ↑ countermovement vertical jump | None reported |
| Skare et al. 2001 | 18 male competitive sprinters | 5 days | 20 g/day for 5 days | 100-m sprint time | ↑ 100 m sprint time | None reported |
| Romer et al. 2001 | 9 competitive squash players | 5 days | 0.075 g/kg 4 times for 5 days | single sprint | ↔ single sprint | None reported |
| Izquierdo et al. 2002 | 19 male handball players | 5 days | 20 g/day for 5 days | countermovement vertical jump | ↑ countermovement vertical jump | None reported |
| Cox et al. 2002 | 12 elite female soccer players | 6 days | 20 g/day for 6 days | agility kick drill test | ↔ kick drill test | None reported |
| Lehmkul et al. 2003 | 29 (17 male, 12 female) track and field athletes | 8 weeks | 0.3 g/kg/day for 7 days | average and peak power during repeated sprints on a cycle ergometer | ↔ static vertical jump | None reported |
| Delecluse et al. 2003 | 12 (7 male, 5 female competitive sprinters | 7 days | 0.35 g/day for 7 days | single 40-m sprint | ↔ single 40 m sprint | None reported |
| Kocak et al. 2003 | 20 elite male wrestlers | 5 days | 20 g/day for 5 days | average and peak power during Wingate anaerobic power test | ↑ average power | None reported |
| Ostojic et al. 2004 | 20 young male soccer players | 7 days | 30 g/day for 7 days | dribbling test | ↑ dribbling test | None reported |
| Pluim et al. 2006 | 36 competitive tennis players | 32 days | 0.3 g/day for 6 days | serve velocity | ↔ serve velocity | None reported |
| Glaister et al. 2006 | 42 active males | 5 days | 20 g/day for 5 days | repetitive sprint performance | ↔ repetitive sprint performance | None reported |
| Lamontagne-Lacasse et al. 2011 | 12 elite male volleyball players | 28 days | 20 g/day in days 1–4 | repeated block jump | ↔ repeated block jump | None reported |
| Ramierz-Campillo et al. 2016 | 30 amateur female soccer players | 6 weeks | 20 g/day for 7 days | jump test | ↑ jump test | None reported |
BLa = blood lactate; CR or no identifier = creatine monohydrate; BLa = blood lactate; ↓ indicates decrease; ↑ indicates increase; ↔ indicates no difference.
Summary of selected studies examining the effects of creatine supplementation on endurance performance.
| Author-Year | Subjects | Duration | Dosing Protocol | Primary Variables | Results | Adverse Events |
|---|---|---|---|---|---|---|
| Rossiter et al. 1996 | 38 (28 male, 10 female) competitive rowers | 5 days | 0.25 g/kg/day for 5 days | time trial performance during rowing ergometry | ↓ 2.3 s in 1000-m times | None reported |
| McNaughton et al. 1998 | 16 elite male paddlers | 5 days | 20 g/day for 5 days | total work, peak power, BLa during rowing ergometry | ↑ in total work during 90–300 s of rowing ergometry performance | None reported |
| Miura et al. 1999 | 8 healthy males | 5 days | 20 g/day for 5 days | critical power test during cycle ergometry | ↔ critical power | None reported |
| Rico-Sanz et al. 2000 | 14 elite male cyclists | 5 days | 20 g/day for 5 days | oxygen consumption, time to exhaustion, BLa during maximal cycle ergometry | ↔ VO2 max | None reported |
| Syrotuik el al. 2001 | 22 (12 male, 10 female) competitive rowers | 6 weeks | 0.3 g/kg/day for 5 days | time trial performance during rowing ergometry | ↔ in 2000-m rowing times | None reported |
| Jones et al. 2002 | 9 active males | 5 days | 20 g/day for 5 days | VO2 kinetics during moderate and heavy submaximal cycle exercise | ↔ VO2 kinetics | None reported |
| Chwalbinska-Moneta 2003 | 16 elite male rowers | 5 days | 20 g/day for 5 days | maximal power output, time to exhaustion, Bla during rowing ergometry | ↔ maximal power output | None reported |
| Graef et al. 2009 | 43 active males | 30 days | 10 g/day for 20 days; only on training days (5 × week) | oxygen consumption, time to exhaustion, VT, total work, during maximal cycle ergometry | ↔ VO2 peak | None reported |
| Kendall et al. 2009 | 43 active males | 30 days | 10 g/day for 20 days; only on training days (5 × week) | critical power and anaerobic work capacity during cycle ergometry | ↑ Critical power | None reported |
| Hickner et al. 2010 | 12 endurance-trained males | 28 days | 3 g/day for 28 days | VO2peak, submaximal VO2, RER, Bla, 10 s sprints at 110% VO2peak during simulated cycling road race | ↔ VO2peak | 2 subjects reported muscle cramping at rest following supplementation |
| De Andrade Nemezio et al. 2015 | 24 male amateur cyclists | 5 days | 20 g/day for 5 days | time trial performance total O2 uptake, BLa during maximal cycle ergometry | ↔ 1000 m time | None reported |
| Forbes et al. 2017 | 17 active females | 28 days | 0.3 g/kg/day for 5 days | VO2peak, VT, peak workload, time trial performance during cycle ergometry | ↔ VO2peak | None reported |
| Fernandez-Landa et al. 2020 | 28 elite male rowers | 10 weeks | 0.04 g/kg/day for 10 weeks | power output at AT, 4 mmol, 8 mmol Bla during rowing ergometry | ↑ power at AT for creatine-HMB and HMB only group | None reported |
BLa = blood lactate; CR or no identifier = creatine monohydrate; RER = respiratory exchange ratio; ↓ indicates decrease; ↑ indicates increase; ↔ indicates no difference.
Summary of selected studies examining the effects of creatine supplementation on indices of muscle damage, inflammation, and recovery.
| Author Year | Subjects | Duration | Dosing Protocol | Primary Variables | Results | Adverse Events |
|---|---|---|---|---|---|---|
| Oopik et al. 2002 | 5 well-trained male wrestlers | 17 hours | 30 g (7.5 g/serving) + 320 g glucose (80 g/serving) over 4 doses | isokinetic performance | ↑ submaximal work | None reported |
| Hespel et al. 2001 | 22 (13 males, 9 females) | 10 weeks | 20 g/day for 3 weeks (immobilization) | quadriceps cross-sectional area (CSA) | ↑ CSA | None |
| Tyler et al. 2004 | 60 ACL reconstruction patients | 6 months | 20 g/day for 7 days | knee extension | ↑ knee outcome measures comparing to baseline | None |
| Rawson et al. 2007 | 22 trained males | 10 days | 0.3 g/kg/day for 5 days | maximal strength | ↔ strength | None |
| Cooke et al. 2009 | 14 untrained males | 20 days | 0.3 g/kg/day + glucose (80 g/day) for 5 days | isokinetic force | ↑ isokinetic force | None |
| Rosene et al. 2009 | 20 healthy males | 30 days | 20 g/day for 7 days | isometric force | ↑ isometric force | None |
| Johnston et al. 2009 | 7 healthy males | 30 days | Maltodextrin 20 g/day for 7 days (Day 1–7) | fat free mass | ↑ lean tissue | None |
| McKinnon et al. 2012 | 27 (15 male, 12 female) untrained subjects | 10 days | 40 g/day + CHO 40 g/day for 5 days | muscle force loss | ↔ force loss | None |
| Boychuk et al. 2016 | 14 healthy males | 48 hours | 0.3 d/kg | maximal voluntary contraction | ↔ strength | None |
| Backx et al. 2017 | 30 healthy males | 12 days | 20 g/day for 5 days | quadriceps cross-sectional area (CSA) | ↔ CSA | None |
1 RM = one repetition maximum; CHO = carbohydrates; CR or no identifier = creatine monohydrate; BLa = blood lactate; ↓ indicates decrease; ↑ indicates increase; ↔ indicates no difference.